MedTrace Logo

Immunity Against AAV in Crigler Najjar Patient

NCT02302690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2017-12-13

No results posted yet for this study

Summary

The proposed research protocol aims at addressing these points by pre-screening CN patients for their AAV serology in link with their medical history and current medical status. A first objective is to assess the presence of neutralizing AAV antibodies in the serum of CN patients.

Conditions

  • Crigler Najjar Syndrome

Interventions

BIOLOGICAL

Blood sample for immunology

Sponsors & Collaborators

  • Genethon

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302690 on ClinicalTrials.gov